Relmada Therapeutics shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Relmada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Relmada Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Relmada Therapeutics by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $2.0M | 296k | 6.92 |
| 2023-12-31 | $46k | 11k | 4.14 |
| 2023-09-30 | $110k | 37k | 3.00 |
| 2023-06-30 | $195k | 79k | 2.46 |
| 2023-03-31 | $347k | 154k | 2.26 |
| 2022-12-31 | $650k | 186k | 3.49 |
| 2022-09-30 | $8.0M | 215k | 37.06 |
| 2022-06-30 | $4.6M | 242k | 18.96 |
| 2022-03-31 | $6.4M | 237k | 27.01 |
| 2021-12-31 | $4.8M | 213k | 22.54 |
| 2021-09-30 | $5.2M | 198k | 26.24 |
| 2021-06-30 | $6.4M | 199k | 32.07 |
| 2021-03-31 | $6.7M | 190k | 35.18 |
| 2020-12-31 | $5.3M | 165k | 32.04 |
| 2020-09-30 | $6.7M | 178k | 37.62 |
| 2020-06-30 | $5.9M | 132k | 44.77 |
| 2020-03-31 | $3.3M | 98k | 34.13 |
| 2019-12-31 | $4.0M | 103k | 39.07 |